Digestive System Neuroendocrine Tumor G2 Clinical Trials in Albuquerque, New Mexico

Comparing Retreatment of 177Lu-DOTATATE PRRT Versus the Usual Treatment in Patients With Metastatic Unresectable Gastroenteropancreatic Neuroendocrine Tumors, NET RETREAT Trial